These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 1944552)

  • 1. Synthetic vaccines. Peptides of fortune.
    Janeway C
    Nature; 1991 Oct; 353(6347):792. PubMed ID: 1944552
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunity to Listeria monocytogenes.
    North RJ; Conlan JW
    Chem Immunol; 1998; 70():1-20. PubMed ID: 9509668
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunomodulation by HLA class I-derived peptides.
    Krensky AM; Clayberger C
    Transplant Proc; 1996 Dec; 28(6):3026-8. PubMed ID: 8962174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological memory to Listeria monocytogenes in rodents: accumulation of Listeria-reactive lymphocytes in the stimulated and unstimulated peritoneal cavity.
    Jungi TW
    J Reticuloendothel Soc; 1981 Jul; 30(1):47-59. PubMed ID: 6167715
    [No Abstract]   [Full Text] [Related]  

  • 5. Cloned Listeria monocytogenes specific non-MHC-restricted Lyt-2+ T cells with cytolytic and protective activity.
    Kaufmann SH; Rodewald HR; Hug E; De Libero G
    J Immunol; 1988 May; 140(9):3173-9. PubMed ID: 3129513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of the Listeria monocytogenes p60-specific CD4 and CD8 T cell memory by nonpathogenic Listeria innocua.
    Geginat G; Nichterlein T; Kretschmar M; Schenk S; Hof H; Lalic-Mülthaler M; Goebel W; Bubert A
    J Immunol; 1999 Apr; 162(8):4781-9. PubMed ID: 10202020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell-mediated cytotoxicity induced by Listeria monocytogenes. I. Activation of Listeria antigen-responsive T cells.
    Woan MC; McGregor DD
    J Immunol; 1981 Dec; 127(6):2319-24. PubMed ID: 6170698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination strategies using viable carrier systems against intracellular pathogens.
    Hess J; Szalay G; Miko D; Gentschev I; Goebel W; Ladel CH; Kaufmann SH
    Behring Inst Mitt; 1994 Dec; (95):67-79. PubMed ID: 7755511
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunology. Brief encounter.
    Welsh RM
    Nature; 2001 May; 411(6837):541-2. PubMed ID: 11385554
    [No Abstract]   [Full Text] [Related]  

  • 10. In silico predictions; in vivo veritas.
    De Groot AS; Rothman FG
    Nat Biotechnol; 1999 Jun; 17(6):533-4. PubMed ID: 10385311
    [No Abstract]   [Full Text] [Related]  

  • 11. Direct sequence identification and kinetic analysis of an MHC class I-restricted Listeria monocytogenes CTL epitope.
    Pamer EG
    J Immunol; 1994 Jan; 152(2):686-94. PubMed ID: 7506732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of inhibitory receptors for MHC class I molecules on T cells.
    Huard B
    Crit Rev Immunol; 2000; 20(6):471-6. PubMed ID: 11396682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-class I-specific inhibitory receptors of NK type on a subset of human T cells.
    Mingari MC; Vitale C; Schiavetti F; Cambiaggi A; Bertone S; Zunino A; Ponte M
    Chem Immunol; 1996; 64():135-45. PubMed ID: 8942077
    [No Abstract]   [Full Text] [Related]  

  • 14. Listeria monocytogenes as novel carrier system for the development of live vaccines.
    Schoen C; Loeffler DI; Frentzen A; Pilgrim S; Goebel W; Stritzker J
    Int J Med Microbiol; 2008 Jan; 298(1-2):45-58. PubMed ID: 17936682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biological role of HLA-C].
    Kuśnierczyk P
    Postepy Hig Med Dosw; 1995; 49(1):33-45. PubMed ID: 8657616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutting edge: expression of functional CD94/NKG2A inhibitory receptors on fetal NK1.1+Ly-49- cells: a possible mechanism of tolerance during NK cell development.
    Sivakumar PV; Gunturi A; Salcedo M; Schatzle JD; Lai WC; Kurepa Z; Pitcher L; Seaman MS; Lemonnier FA; Bennett M; Forman J; Kumar V
    J Immunol; 1999 Jun; 162(12):6976-80. PubMed ID: 10358137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
    Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
    J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple effector mechanisms induced by recombinant Listeria monocytogenes anticancer immunotherapeutics.
    Wallecha A; Carroll KD; Maciag PC; Rivera S; Shahabi V; Paterson Y
    Adv Appl Microbiol; 2009; 66():1-27. PubMed ID: 19203646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neural network-based prediction of candidate T-cell epitopes.
    Honeyman MC; Brusic V; Stone NL; Harrison LC
    Nat Biotechnol; 1998 Oct; 16(10):966-9. PubMed ID: 9788355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An accelerated vaccine schedule with a poly-antigenic hepatitis C virus MVA-based candidate vaccine induces potent, long lasting and in vivo cross-reactive T cell responses.
    Fournillier A; Gerossier E; Evlashev A; Schmitt D; Simon B; Chatel L; Martin P; Silvestre N; Balloul JM; Barry R; Inchauspé G
    Vaccine; 2007 Oct; 25(42):7339-53. PubMed ID: 17875349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.